+ Background
+ Our Associates
About
Company background
The Winslow philosophy
Account Resources
Cybersecurity
Important information for investors
Rising interest rate risks
SEC Rule 606 – Order routing
Tax Form Downloads to TurboTax®
Contact
Contact associates
Directions – Boston Headquarters
Directions – Braintree, MA
Directions – New York City
Directions – Paramus, NJ
Financial Results
FIND AN ADVISOR
+ by Branch
+ by Name
Booth, Thomas A.
Bridges, John
Caperton, Nomi
Cully, Robert M.
Davis, Jeffrey
deVillier, Shawn M.
Figenbaum, Kimberly, CFP®, CRPC®
Fishman, Jeffrey K.
Folta, Rand G., CFA
Ingram, Mark, CFA
Julian, Raymond, CFP®
Kong, Dolores, CFP®, EA
Lee, Shaun
Maloney, Robert B.
Maloney, Tina B.
McNevin, Barnes A. C., III
O’Brien, Kyle
Perkins Jr., Richard S.
Sbano, Vincent J.
Stone, Christopher
Strimaitis, David
White, Douglas, CFA
HOME
INDIVIDUAL INVESTORS
+ Insure your future
+ Annuities: “Income for life”
+ Life insurance: Whole and variable
+ Long-term care
+ Property and casualty
+ Invest and trade
+ Client support
+ Tax-advantaged investing
+ Trading desk services
+ Plan for life
+ What to expect: Six steps
+ Plan for retirement
+ Save for college
+ What approach is right for me?
+ Brokers
+ Choosing a financial professional and firm
+ Investment advisors
INSTITUTIONAL INVESTORS
+ Equity trading
+ Fixed income
+ Municipal desk
News
Commentary library
Philanthropy at Winslow
Spotlight: Barnes McNevin
OPPORTUNITIES AT WINSLOW
+ Business partners
+ Financial advisors
+ Other Opportunities – REFERENCE ONLY
+ Working with Winslow
Search Results
Site map
Test PW protected page
Account Login
+ Background
+ Our Associates
About
Company background
The Winslow philosophy
Account Resources
Cybersecurity
Important information for investors
Rising interest rate risks
SEC Rule 606 – Order routing
Tax Form Downloads to TurboTax®
Contact
Contact associates
Directions – Boston Headquarters
Directions – Braintree, MA
Directions – New York City
Directions – Paramus, NJ
Financial Results
FIND AN ADVISOR
+ by Branch
+ by Name
Booth, Thomas A.
Bridges, John
Caperton, Nomi
Cully, Robert M.
Davis, Jeffrey
deVillier, Shawn M.
Figenbaum, Kimberly, CFP®, CRPC®
Fishman, Jeffrey K.
Folta, Rand G., CFA
Ingram, Mark, CFA
Julian, Raymond, CFP®
Kong, Dolores, CFP®, EA
Lee, Shaun
Maloney, Robert B.
Maloney, Tina B.
McNevin, Barnes A. C., III
O’Brien, Kyle
Perkins Jr., Richard S.
Sbano, Vincent J.
Stone, Christopher
Strimaitis, David
White, Douglas, CFA
HOME
INDIVIDUAL INVESTORS
+ Insure your future
+ Annuities: “Income for life”
+ Life insurance: Whole and variable
+ Long-term care
+ Property and casualty
+ Invest and trade
+ Client support
+ Tax-advantaged investing
+ Trading desk services
+ Plan for life
+ What to expect: Six steps
+ Plan for retirement
+ Save for college
+ What approach is right for me?
+ Brokers
+ Choosing a financial professional and firm
+ Investment advisors
INSTITUTIONAL INVESTORS
+ Equity trading
+ Fixed income
+ Municipal desk
News
Commentary library
Philanthropy at Winslow
Spotlight: Barnes McNevin
OPPORTUNITIES AT WINSLOW
+ Business partners
+ Financial advisors
+ Other Opportunities – REFERENCE ONLY
+ Working with Winslow
Search Results
Site map
Test PW protected page
INDIVIDUAL INVESTORS
+ What approach is right for me?
+ Choosing a financial professional
+ Brokers
+ Investment advisors
+ The Winslow philosophy
+ Plan for life
+ What to expect: Six steps
+ Plan for retirement
+ Save for college
+ Invest and trade
+ Tax-advantaged investing
+ Trading desk services
+ Client support
+ Insure your future
+ Life insurance
+ Annuities: “Income for life”
+ Property and casualty
+ Submit your current policy
+ Long-term care
INSTITUTIONAL INVESTORS
+ Equity trading
+ Fixed income
+ Municipal desk
FIND AN ADVISOR
+ by Name
+ by Branch
OPPORTUNITIES AT WINSLOW
+ Financial advisors
+ Business partners
+ Working with Winslow
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
250.73
+1.03 (+0.41%)
Streaming Delayed Price
Updated: 10:00 AM EDT, Aug 19, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Amgen
Two Appealing Biotech Stocks for Two Distinct investors
August 08, 2022
Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles
Via
MarketBeat
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
ChemoCentryx (NASDAQ: CCXI) to be Acquired by Amgen (NASDAQ: AMGN) for $3.7 Billion in Cash
August 04, 2022
ChemoCentryx, Inc. (NASDAQ: CCXI) is engaged as a biopharmaceutical company that is focused on the research, development and commercialization of
Via
Spotlight Growth
Should You Buy AbbVie Ahead Of Earnings?
July 28, 2022
AbbVie (NYSE: ABBV) is due to announce its earnings over the next couple of days. Some investors are considering buying it in advance, but it is worth the investment?
Via
MarketBeat
Amgen Inc. (NASDAQ:AMGN) Investor Alert: Investigation over Potential Wrongdoing
July 07, 2022
San Diego, CA -- (SBWIRE) -- 07/07/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Amgen Inc.
Via
SBWire
Rising Cases Of Mental Health Disorders of Stress, Anxiety & Addiction Fueling Need for Central Nervous System Therapeutics
June 07, 2022
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic and are still...
Via
FinancialNewsMedia
Exposures
COVID-19
NASDAQ: AMGN Investor Notice: Investigation over Possible Securities Laws Violations by Amgen Inc.
May 11, 2022
San Diego, CA -- (SBWIRE) -- 05/11/2022 -- An investigation was announced for investors of Amgen Inc. (NASDAQ: AMGN) shares over potential securities laws violations by Amgen Inc.
Via
SBWire
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
May 04, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
May 03, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
May 03, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
May 02, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
April 29, 2022
From
The Schall Law Firm
Via
Business Wire
Promising Results Continue to Develop Optimism in Fight Against Cancers
January 27, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 27, 2021 – USA News Group – There’s plenty of optimism surrounding the major medical breakthroughs targeting multiple types...
Via
FinancialNewsMedia
Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement
January 06, 2022
From
Generate Biomedicines
Via
Business Wire
Artificial Intelligence Being Used to Accurately Predict Synergistic Cancer Drug Combinations
December 10, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –December 10, 2021 – USA News Group – Researchers led by a scholar from City University of Hong Kong (CityU) have developed a novel...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options
December 21, 2021
Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to...
Via
FinancialNewsMedia
Exposures
Product Safety
A Growing Market For Rare Disease Treatments Opens Up New Opportunities
April 28, 2021
Via
FinancialNewsMedia
Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027
December 08, 2021
Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The...
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Market Action
Symbol Lookup
MARKET NEWS